TrialRheumatology (Oxford, England)2010

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR).

Andrea Rubbert-Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.